Recombinant AAV Vectors and Gene Therapies for Treating Brain Diseases
The invention discloses a recombinant adeno-associated virus (AAV) vector engineered to introduce the expression of GPR173 in neurons, specifically targeting brain regions involved in E/I imbalances.
Prof. HE Jufang, Prof. CHEN Xi, Dr. HE Ling, Dr. SHI Heng, Dr. YANG Yujie, Dr. ZHANG Ge, Mr. YOON Ezra Ginn, Mr. LAU Siu Hin
-
Recombinant AAV Vector
-
GPR173
-
Gene Therapy
-
GABAergic Neurons
-
Excitatory
-
Neurological Disorders
-
Epilepsy
-
Brain Disorders
-
Genetic Engineering
